Docoh
Loading...

RVP Retractable

Retractable Technologies, Inc. manufactures and markets safety needle devices for the healthcare industry. Its products are designed to protect healthcare workers, patients, and others from needlestick injuries, cross-contamination through reuse, and reduce disposal costs. Its products include VanishPoint and Patient Safe Syringes, EasyPoint Needles, VanishPoint Blood Collection Sets and Tube Holders, VanishPoint IV Catheters. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.

Company profile

Ticker
RVP
Exchange
CEO
Thomas J. Shaw
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
752599762

RVP stock data

(
)

Calendar

17 May 21
31 Jul 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Retractable earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
12 May 21 Laterza Marco Option (non-qualified) Common Stock Dispose X No No 1.05 5,000 5.25K 20,000
22 Apr 21 Bigby Walter O Jr Common Stock Sell Dispose S No No 10.02 5,000 50.1K 90,000
16 Mar 21 John W Fort III Option (non-qualified) Common Stock Grant Aquire A No No 13 1 13 92,308
16 Mar 21 John W Fort III Option (incentive) Common Stock Grant Aquire A No No 13 1 13 7,692
16 Mar 21 Larios Michele Option (non-qualified) Common Stock Grant Aquire A No No 13 1 13 242,308
16 Mar 21 Larios Michele Option (incentive) Common Stock Grant Aquire A No No 13 1 13 7,692
16 Mar 21 Shaw Thomas J Option (non-qualified) Common Stock Grant Aquire A No No 13 1 13 1,000,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

15.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 70 70
Opened positions 15 19 -21.1%
Closed positions 15 9 +66.7%
Increased positions 18 24 -25.0%
Reduced positions 26 20 +30.0%
13F shares
Current Prev Q Change
Total value 91.12M 99.65M -8.6%
Total shares 5.17M 6.36M -18.7%
Total puts 487.4K 525K -7.2%
Total calls 457.9K 550.3K -16.8%
Total put/call ratio 1.1 1.0 +11.6%
Largest owners
Shares Value Change
BLK Blackrock 1.01M $12.95M +0.7%
Vanguard 809.26K $10.38M +4.9%
Victory Capital Management 307.44K $3.94M NEW
Renaissance Technologies 302.1K $3.87M -69.8%
STT State Street 246.51K $3.16M -2.7%
Susquehanna International 229.48K $2.94M -10.1%
Geode Capital Management 221.95K $2.85M +13.3%
WFC Wells Fargo & Co. 205.02K $2.63M +234.5%
Newtyn Management 200K $2.56M -11.1%
NTRS Northern Trust 192.19K $2.46M -16.0%
Largest transactions
Shares Bought/sold Change
Renaissance Technologies 302.1K -697.1K -69.8%
THB Asset Management 0 -385.4K EXIT
Victory Capital Management 307.44K +307.44K NEW
MS Morgan Stanley 18.44K -189.55K -91.1%
WFC Wells Fargo & Co. 205.02K +143.72K +234.5%
GS Goldman Sachs 121.47K +121.47K NEW
Arrowstreet Capital, Limited Partnership 0 -110.75K EXIT
D. E. Shaw & Co. 130.51K +109.04K +508.0%
O'shaughnessy Asset Management 41.36K -84.71K -67.2%
Nuveen Asset Management 41.76K -76.42K -64.7%

Financial report summary

?
Management Discussion
  • Domestic sales, including sales to the U.S. government, accounted for 90.2% and 76.3% of the revenues in 2020 and 2019, respectively. Domestic revenues increased 131.4% principally due to increased volumes. Domestic unit sales increased 120.0%. Domestic unit sales were 85.9% of total unit sales for 2020. Domestic unit sales excluding the HHS Order rose approximately 36.4%. International revenues decreased 18.6% representing a return to normal levels after unusually high volumes in 2019. Our international orders may be subject to significant fluctuation over time. Overall unit sales increased 74.0%. Other than the Department of Health and Human Services, our increased sales are predominantly attributable to existing customers as well as several new smaller customers who do not operate as distributors. Our sales under the HHS Order were approximately $31.6 million in 2020 and we expect the remaining sales under the HHS Order in 2021, as well as orders of at least $54.2 million under the new February 2021 contract.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: abovementioned, accuracy, affirmed, apportionment, Assistant, Committee, Compensation, counsel, counterparty, criterion, dead, dose, employed, entertainment, entirety, examination, examine, expiration, extent, filled, foregoing, greatly, imputed, incentive, intent, likelihood, low, matching, modified, month, notice, notified, past, pronounced, reconciliation, relevant, renewal, residual, rest, retroactive, retroactively, salary, Secretary, temporary, Update, verified, vest
Removed: agreed, amended, amortize, aspirate, bloodstream, choose, collect, Commencing, contamination, evaluating, executed, exempt, fluctuate, fully, hub, law, Lender, lock, monthly, payroll, prefilled, prepaid, redeemed, reduced, registration, relying, reserve, resulted, scheduled, slip, tendered, uniquely, unusually, waive, waiver